GH1 and Prader-Willi syndrome: Similar magnitudes of improvement in HQ-CT in the C601/C602 cohort compared to the PATH for PWS cohort were realized in both pediatric and adult participants, in females and males, and in growth hormone treated and naïve subgroups.